Press-release for stocks in the transportation and warehousing sector related to drug

Prices are updated after-hours

| 72276.68% | O: -9.87% H: 19.4% C: 19.4%
glaucoma drug bioscience trial

Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE
Published: 2022-12-20 (Crawled : 17:00) - biospace.com/
SKYE | $16.16 -4.77% -5.01% 110K

| 129020.0% | O: 4.8% H: 14.5% C: -8.4%
sbi-100 fda drug application authorization bioscience

Skye Bioscience Submits Investigational New Drug Application for SBI-100 Ophthalmic Emulsion to FDA
Published: 2022-11-17 (Crawled : 14:20) - biospace.com/
SKYE | $16.16 -4.77% -5.01% 110K

| 72276.68% | O: 12.11% H: 3.6% C: -32.0%
sbi-100 fda drug application bioscience ophthalmic emulsion

Skye Bioscience Completes Drug Production for Phase 1 Clinical Study
Published: 2022-09-20 (Crawled : 12:00) - biospace.com/
SKYE | $16.16 -4.77% -5.01% 110K

| 67150.0% | O: 0.0% H: 15.83% C: 0.0%
drug bioscience study phase 1

Skye Bioscience Retains Novotech as CRO for Phase 1 Trial of Glaucoma Drug Candidate
Published: 2022-03-03 (Crawled : 17:00) - biospace.com/
SKYE | $16.16 -4.77% -5.01% 110K

| 41178.77% | O: 0.0% H: 7.42% C: 0.26%
glaucoma drug trial phase 1 bioscience phase 2 phase 3

67%

33%

AGBA | News | $1.26 215.0% 68.25% 130M

EGOX | $0.0515 43.06% 30.1% 330M

OLB 4 | $0.33 -14.95% 25.53% 840K

NVFY | $2.77 31.28% 23.83% 33M

ZCMD | $1.87 28.97% 22.46% 31M

RCON | $0.1112 13.01% 21.28% 1.7M

INSG | $3.03 25.21% 20.13% 330K

GCTK | $0.8191 22.25% 18.2% 190K

WLGS | $0.59 18.0% 17.9% 2.3M

ASNS | $0.828 21.75% 17.86% 18K

Save your searches and get alerts when important news are released.